Skip to main content

A new PCR-based mass spectrometry system for high-risk HPV, part II: clinical trial.

Du H, Yi J, Wu R, Belinson SE, Qu X, Yang B, Wang C, Yi X, Belinson JL

Publication: Am J Clin Pathol (2011) • Vol 136 • Page 920-3PMID: 22095378View on PubMed

Purpose

The purpose of this paper was to determine the effects of self-collection and assay type on the detection of human papillomavirus (HPV) in cervical specimens.

Conclusion

HPV was detected in 13.6%, 11.1% and 11.9% of specimens by the hybrid capture 2 (HC2) hybridization assay, the amplification based Cervista assay and PCR-MALDI-TOF, respectively. While the sensitivity for cervical intraepithelial neoplasia (CIN) 3 or worse did not differ between the three assays, the specificity of the Cervista assay was greater than that for the PCR-MALDI-TOF or HC2 assays. When self-collected specimens were assayed by MALDI-TOF, the sensitivity was similar to that observed after analysis of clinician-collected specimens by each of the three methods.

Studies (1)

Purpose

The purpose of this study was to determine the effects of self-collection and assay type on the detection of HPV in cervical specimens.

Summary of Findings

HPV was detected in 13.6%, 11.1% and 11.9% of specimens by the hybridization based HC2, the amplification based Cervista and PCR-MALDI-TOF assays, respectively. While the sensitivity for CIN 3 or more did not differ between the three assays, the specificity of the Cervista assay was greatest followed by the PCR-MALDI-TOF assay and then the HC2 assay. When self-collected specimens were assayed by MALDI-TOF, the sensitivity was similar to that observed after analysis of clinician-collected specimens by each of the three methods.

  • Biospecimens

    CellCervix
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Not specified
  • Platforms

    DNASouthern blot
    DNAPCR
    DNAMALDI-TOF MS
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    HPV
    Biospecimen AcquisitionMethod of cell acquisition
    Cervical smear
    Clinic collected cytological brush
    Self-administered cytological brush
    MALDI-TOF MS SpecificTechnology platform
    Cervista
    HC2